How an experimental weight-loss drug is being openly promoted by physicians

The buzz around an experimental weight-loss drug has doctors prescribing it despite it not yet having FDA approval, driven by its viral social media hype. Some physicians are questioning why they should wait for official approval when patients are clamoring for it. This situation highlights the growing tension between traditional medical approval processes and the fast-paced world of social media, raising questions about patient safety and the influence of online trends on medical decisions. The implications could be significant, affecting how future medications are marketed and approved.